Xuexia Zhou

3PUBLICATIONS
1CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 14, 2025
ZNRF2 is essential for gliomagenesis through orchestrating glycolysis and acts as a promising therapeutic target in glioma.

Yunlan Xi, Qingqing Yang, Yixuan Wang

|Jul 09, 2024
Correction: Recruitment of LEF1 by Pontin chromatin modifier amplifies TGFBR2 transcription and activates TGFβ/SMAD signalling during gliomagenesis.

Xuexia Zhou, Xuebing Li, Run Wang

|Sep 24, 2022
Recruitment of LEF1 by Pontin chromatin modifier amplifies TGFBR2 transcription and activates TGFβ/SMAD signalling during gliomagenesis.

Xuexia Zhou, Xuebing Li, Run Wang

Pageof 1

Frequent Collaborators

2 joint publications

Lin Yu